These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23109693)

  • 41. [Surgical Outcome of Palliative Surgery for Gastric Cancer Patients with Bowel Obstruction Due to Peritoneal Dissemination].
    Kawabata R; Yoshikawa M; Kameda C; Takata A; Yasuyama A; Matsumura T; Koga C; Murakami M; Hirota M; Noura S; Shimizu J; Hasegawa J
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1576-1578. PubMed ID: 28133062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palliative surgery for intestinal obstruction due to recurrent ovarian cancer.
    Parveen Z; Qureshi AN; Akbar M; Zafar A; Subhani A
    J Ayub Med Coll Abbottabad; 2009; 21(1):135-6. PubMed ID: 20364762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of somatostatin analogs in the management of medullary thyroid carcinoma.
    Lupoli GA; Fonderico F; Fittipaldi MR; Colarusso S; Panico A; Cavallo A; Di Micco L; Lupoli G
    J Endocrinol Invest; 2003; 26(8 Suppl):72-4. PubMed ID: 15233217
    [No Abstract]   [Full Text] [Related]  

  • 44. [Accidental finding of a malignancy during surgery for unusual intestinal obstruction in a female patient following kidney transplantation].
    Houdek K; Sulc R; Treska V; Molácek J
    Rozhl Chir; 2009 Apr; 88(4):189-91. PubMed ID: 19645144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diffuse malignant peritoneal mesothelioma presenting as intestinal obstruction.
    Griniatsos J; Sougioultzis S; Dimitriou N; Vamvakopoulou V; Alexandrou P; Kyriakou V; Tzioufas A; Papalambros E; Tzivras M
    South Med J; 2009 Oct; 102(10):1061-4. PubMed ID: 19738519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Palliative parenteral nutrition use in patients with intestinal failure as a consequence of advanced pseudomyxoma peritonei: a case series.
    Disney BR; Karthikeyakurup A; Ratcliffe J; Jones J; Deel-Smith P; Fairhurst A; Maleki K; Cooper SC
    Eur J Clin Nutr; 2015 Aug; 69(8):966-8. PubMed ID: 26105107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lymphangioma of the mesentery as the cause of intestinal obstruction].
    Varmarken JE; Dalsgaard S
    Ugeskr Laeger; 1987 Feb; 149(9):598-9. PubMed ID: 3824669
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of somatulin in clinical practice].
    Grigor'ev KB; Zuev VK; Bokachev RA
    Klin Med (Mosk); 2004; 82(12):59-61. PubMed ID: 15732723
    [No Abstract]   [Full Text] [Related]  

  • 49. Lanreotide autogel is a therapeutic option for patients who develop acute pancreatitis after somatostatin analog treatment.
    Boix E; López P; Pérez-Mateo M; Picó A
    J Endocrinol Invest; 2004 Jun; 27(6):613-4. PubMed ID: 15717663
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical utility of lanreotide Autogel
    Paragliola RM; Prete A; Papi G; Torino F; Corsello A; Pontecorvi A; Corsello SM
    Drug Des Devel Ther; 2016; 10():3459-3470. PubMed ID: 27822010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solitary mesenteric plasmacytoma revealed by an acute intestinal obstruction.
    Jarry J
    Gastroenterol Clin Biol; 2009 May; 33(5):432-4. PubMed ID: 19359115
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intestinal obstruction in the newborn infant caused by cavernous mesenteric lymphangioma].
    Sarić V; Laganin N; Karadza J; Poleksić I; Pikula B
    Acta Chir Iugosl; 1975; 22(1 Suppl):241-2. PubMed ID: 1235628
    [No Abstract]   [Full Text] [Related]  

  • 53. [Intestinal obstruction caused by cavernous lymphangioma of the mesentery in a newborn infant].
    Sarić V; Laganin N; Karadza J; Pikula B; Poleksić I
    Lijec Vjesn; 1975 Jul; 97(7):408-10. PubMed ID: 1214562
    [No Abstract]   [Full Text] [Related]  

  • 54. Why not octreotide?
    Mercadante S
    Support Care Cancer; 1994 May; 2(3):205-6. PubMed ID: 7913384
    [No Abstract]   [Full Text] [Related]  

  • 55. Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors.
    Faiss S; Räth U; Mansmann U; Caird D; Clemens N; Riecken EO; Wiedenmann B
    Digestion; 1999; 60(5):469-76. PubMed ID: 10473972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of octreotide in malignant bowel obstruction.
    Krammer LM
    Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
    [No Abstract]   [Full Text] [Related]  

  • 57. Percutaneous endoscopic gastrostomy tube occlusion in malignant peritoneal carcinomatosis-induced bowel obstruction.
    Vashi PG; Dahlk S; Vashi RP; Gupta D
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1069-73. PubMed ID: 21975697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lymphangioma of the mesentery as a cause of intestinal occlusion].
    Chmura S; Matlak J
    Pol Przegl Chir; 1975 Sep; 47(9A):81-2. PubMed ID: 1187485
    [No Abstract]   [Full Text] [Related]  

  • 59. [Intestinal obstruction caused by peritoneal carcinomatosis due to signet ring cell carcinoma of the breast].
    Pérez JA; Cardemil B; del Pozo M; Avendaño R
    Rev Med Chil; 1995 May; 123(5):617-23. PubMed ID: 8525209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Intestinal obstruction by metastasis in mesentery from squamous cell lung carcinoma].
    Meneses Grasa Z; Coll Salinas A; Macías Cerrolaza JA; Aguayo Albasini JL; Campillo Soto A; Guillén Paredes MP
    Rev Esp Enferm Dig; 2009 Nov; 101(11):817-8. PubMed ID: 20001163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.